220 related articles for article (PubMed ID: 30888638)
1. Expanded Expression of Toll-Like Receptor 2 in Proliferative Verrucous Leukoplakia.
Koh J; Kurago ZB
Head Neck Pathol; 2019 Dec; 13(4):635-642. PubMed ID: 30888638
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic analysis of verrucous hyperplasia, verrucous carcinoma and squamous cell carcinoma as part of the clinicopathologic spectrum of oral proliferative verrucous leukoplakia: A literature review and analysis.
Akrish S; Eskander-Hashoul L; Rachmiel A; Ben-Izhak O
Pathol Res Pract; 2019 Dec; 215(12):152670. PubMed ID: 31630872
[TBL] [Abstract][Full Text] [Related]
3. Proliferative verrucous leukoplakia and its related lesions.
Batsakis JG; Suarez P; el-Naggar AK
Oral Oncol; 1999 Jul; 35(4):354-9. PubMed ID: 10645398
[TBL] [Abstract][Full Text] [Related]
4. Proliferative verrucous leukoplakia: a case report of multiple metachronous oral verrucous carcinoma.
Lombardi N; Varoni EM; Franchini R; Lodi G
BMJ Case Rep; 2023 Nov; 16(11):. PubMed ID: 37967933
[TBL] [Abstract][Full Text] [Related]
5. [Proliferative verrucous leukoplakia. Report of five cases].
Reichart PA; Philipsen HP
Mund Kiefer Gesichtschir; 2003 May; 7(3):164-70. PubMed ID: 12764683
[TBL] [Abstract][Full Text] [Related]
6. Proliferative verrucous leukoplakia: report of two cases and a discussion of clinicopathology.
Greer RO; McDowell JD; Hoernig G
J Calif Dent Assoc; 1999 Apr; 27(4):300-5, 308-9. PubMed ID: 10528563
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-alpha overexpression in proliferative verrucous leukoplakia and oral squamous cell carcinoma: an immunohistochemical study.
Kannan R; Bijur GN; Mallery SR; Beck FM; Sabourin CL; Jewell SD; Schuller DE; Stoner GD
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1996 Jul; 82(1):69-74. PubMed ID: 8843456
[TBL] [Abstract][Full Text] [Related]
8. Potentially malignant disorders revisited-The lichenoid lesion/proliferative verrucous leukoplakia conundrum.
Thomson PJ; Goodson ML; Smith DR
J Oral Pathol Med; 2018 Jul; 47(6):557-565. PubMed ID: 29663518
[TBL] [Abstract][Full Text] [Related]
9. Whole genome DNA methylation and mutational profiles identify novel changes in proliferative verrucous leukoplakia.
Okoturo E; Green D; Clarke K; Liloglou T; Boyd MT; Shaw RJ; Risk JM
Oral Surg Oral Med Oral Pathol Oral Radiol; 2023 Jun; 135(6):893-903. PubMed ID: 37088660
[TBL] [Abstract][Full Text] [Related]
10. Proliferative verrucous leukoplakia: recognition and differentiation from conventional leukoplakia and mimics.
Gillenwater AM; Vigneswaran N; Fatani H; Saintigny P; El-Naggar AK
Head Neck; 2014 Nov; 36(11):1662-8. PubMed ID: 24115154
[TBL] [Abstract][Full Text] [Related]
11. A Retrospective 20-Year Analysis of Proliferative Verrucous Leukoplakia and Its Progression to Malignancy and Association with High-risk Human Papillomavirus.
Upadhyaya JD; Fitzpatrick SG; Islam MN; Bhattacharyya I; Cohen DM
Head Neck Pathol; 2018 Dec; 12(4):500-510. PubMed ID: 29427033
[TBL] [Abstract][Full Text] [Related]
12. Proliferative verrucous leukoplakia: a clinicopathological comparative study.
Alkan U; Bachar G; Nachalon Y; Zlotogorsky A; Levin EG; Kaplan I
Int J Oral Maxillofac Surg; 2022 Aug; 51(8):1027-1033. PubMed ID: 35065850
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptor 2 is present in the microenvironment of oral squamous cell carcinoma.
Ng LK; Rich AM; Hussaini HM; Thomson WM; Fisher AL; Horne LS; Seymour GJ
Br J Cancer; 2011 Feb; 104(3):460-3. PubMed ID: 21179035
[TBL] [Abstract][Full Text] [Related]
14. Abnormal p53 Immunohistochemical Patterns Shed Light on the Aggressiveness of Oral Epithelial Dysplasia.
Novack R; Zhang L; Hoang LN; Kadhim M; Ng TL; Poh CF; Kevin Ko YC
Mod Pathol; 2023 Jul; 36(7):100153. PubMed ID: 36906072
[TBL] [Abstract][Full Text] [Related]
15. Proliferative verrucous leukoplakia: a concise update.
Bagan J; Scully C; Jimenez Y; Martorell M
Oral Dis; 2010 May; 16(4):328-32. PubMed ID: 20233330
[TBL] [Abstract][Full Text] [Related]
16. Proliferative verrucous leukoplakia: a potentially malignant disorder involving periodontal sites.
Gandolfo S; Castellani R; Pentenero M
J Periodontol; 2009 Feb; 80(2):274-81. PubMed ID: 19186968
[TBL] [Abstract][Full Text] [Related]
17. Optimal Management of Proliferative Verrucous Leukoplakia: A Systematic Review of the Literature.
Abadie WM; Partington EJ; Fowler CB; Schmalbach CE
Otolaryngol Head Neck Surg; 2015 Oct; 153(4):504-11. PubMed ID: 26044786
[TBL] [Abstract][Full Text] [Related]
18. Identification of Proteomic Biomarkers in Proliferative Verrucous Leukoplakia through Liquid Chromatography With Tandem Mass Spectrometry.
Arroyo E; Pérez Sayáns M; Bravo SB; de Oliveira Barbeiro C; Paravani Palaçon M; Chamorro Petronacci CM; García Vence M; Chantada Vázquez MDP; Blanco Carrión A; Suárez Peñaranda JM; García García A; Gándara Vila P; Días Almeida J; Veríssimo da Costa GC; Sousa Nogueira FC; Medeiros Evaristo JA; de Abreu Pereira D; Rintala M; Salo T; Rautava J; Padín Iruegas E; Oliveira Alves MG; Morandin Ferrisse T; Albergoni da Silveira H; Esquiche León J; Vilela Silva E; Flores IL; Bufalino A
Lab Invest; 2023 Oct; 103(10):100222. PubMed ID: 37507024
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological features and immunohistochemical expression of p53, Ki-67, Mcm-2 and Mcm-5 in proliferative verrucous leukoplakia.
Gouvêa AF; Vargas PA; Coletta RD; Jorge J; Lopes MA
J Oral Pathol Med; 2010 Jul; 39(6):447-52. PubMed ID: 20412398
[TBL] [Abstract][Full Text] [Related]
20. Proliferative verrucous leukoplakia: an elusive disorder.
Parashar P
J Evid Based Dent Pract; 2014 Jun; 14 Suppl():147-53.e1. PubMed ID: 24929599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
